TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

OPTI-OX

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

OPTI-OX

ST13

US500000079293252

Classe

1, 5, 9, 29, 40, 42

Pedido

79293252

Registro

6391962

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

31

Atualização mais recente

23/06/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5, 9, 29, 40, 42

Data de depósito

09/07/2020

Data de registro

22/06/2021

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

22/06/2021

Última transação

23/06/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

98

Localização do titular

GB

Examinador

RUTLAND, BARBARA A

Unidade examinadora

L10

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

Bit Bio Limited

Representantes

Katrina G. Hull Markery Law, LLC

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 9Classe 29Classe 40Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Stem cells for research purposes; stem cells for scientific purposes; stem cells other than for medical or veterinary purposes; skeletal myocytes for research purposes; cortical neurons for research purposes; biological human tissue for research and scientific purposes; biological tissue cultures other than for medical or veterinary purposes; cultures of cell media for scientific and research use; chemical reagents for use in biotechnology, other than for medical or veterinary use; nutritive agents for processing living cells other than for medical use; semi-processed natural proteins for manufacturing food; proteins for use in the manufacture of food products; proteins for use in recombinant DNA technology other than for medical use

Classe 5

Pharmaceuticals in the nature of cell therapeutics for medical, therapeutic or clinical use; genetically or otherwise modified cells for medical or clinical use; cells which are propagated, cultivated and expanded in bioreactors for medical or clinical use; cells for the purpose of tissue regeneration for medical or clinical use; living cells for medical use; cells for medical use; diagnostic preparations for medical and veterinary purposes; cell preparations for medical use in drug screening; cell preparations for genetic testing and screening for clinical and medical use; stem cells for medical purposes; stem cells for veterinary purposes; cell growth media for growing cells, tissue culture media, cytokines, antibodies and reagents for medical and diagnostic or clinical use; tissue culture media growth factors in the nature of cell growth, cell growth media and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells all for medical and clinical use; cell separation reagents for medical and clinical use; dietary supplements; protein supplements; nutrition supplements

Classe 9

Downloadable and recorded computer software and computer hardware for the separation of biological and non-biological materials; downloadable and recorded bioinformatics software for collection of information on biological materials; downloadable and recorded software for the control of laboratory robots; downloadable and recorded software program for medical, clinical, research and biomanufacturing purposes, namely, downloadable and recorded software for conducting medical and clinical research and control laboratory biomanufacturing robots; bioreactors for biomanufacturing; bioreactors for research use; bioreactor for cell culturing; bioreactors for laboratory use; downloadable and recorded computer-aided manufacturing software for the separation of biological and non-biological materials; smart manufacturing system controls for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; electronic control units for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; laboratory apparatus for magnetic cell separation, namely, apparatus for the separation of cell populations for medical or clinical use; all the aforesaid goods excluding use for non-medical oxygen measurement

Classe 29

Meat; meat substitutes; tissue engineered meat; synthetic meat; cultured meat; laboratory-grown meat; fish, not live

Classe 40

Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; custom manufacture of stem cells for research purposes, stem cells for scientific purposes, stem cells other than for medical or veterinary purposes, skeletal myocytes for research purposes, cortical neurons for research purposes, biological tissue for research and scientific purposes, biological tissue cultures other than for medical or veterinary purposes, cultures of cell media other than for medical or veterinary use, chemical reagents for use in biotechnology, other than for medical or veterinary use, nutritive agents for processing living cells other than for medical use, semi-processed natural proteins for manufacturing food, proteins for use in the manufacture of food products, proteins for use in recombinant dna technology other than for medical use, cell therapeutics, genetically or otherwise modified cells, cells which are propagated, cultivated and expanded in bioreactors, cells for the purpose of tissue regeneration, living cells for medical use, cells for medical use, biological preparations for medical use, diagnostic preparations for medical and/or veterinary purposes, cell preparations for drug screening, cell preparations for genetic testing, screening, stem cells for medical purposes, stem cells for veterinary purposes, cell growth media, tissue culture media, cytokines, antibodies, and reagents for medical, medical research or diagnostic use, tissue culture media, growth factors, growth media, serum, and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells, cell separation reagents, magnetic cell separation equipment, dietary supplements, protein supplements, nutrition supplements, meat, meat substitutes, tissue engineered meat, synthetic meat, cultured meat, laboratory-grown meat and fish, not live

Classe 42

Biotechnology research; scientific testing for others in the area of biotechnology for research, clinical, therapeutic and manufacturing purposes; stem cell research; synthetic biology services, namely biological research; stem cell biology services, namely, biological research; scientific services for research, clinical, therapeutic and manufacturing purposes relating to the isolation and cultivation of human tissues and cells; research and development in the field of microorganisms and cells; research and development in relation to genetic testing, screening; research and development in relation to drug screening; cell separation technology services, namely, research of technology in the field of cell separation; cell separation research services; consultancy relating to biotechnology; scientific and research consultancy relating to drug screening for forensic research purposes; scientific and research consultancy relating to genetic screening; scientific and research consultancy relating to cell therapy; laboratory research in the field of drug discovery, cell therapy, stem cells, microorganisms, human tissues, synthetic biology and manufacturing; research on food; research and development in the field of animal cells cultivated within bioreactors; research in the reduction of carbon emissions; development and testing of computing methods, software algorithms and software for medical, clinical, research and biomanufacturing purposes

Publicações

Histórico de despachos e eventos da marca no USPTO.

31 publicações encontradas

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

22/06/2026

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

08/01/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

14/02/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

08/11/2024

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/05/2024

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

04/11/2021

FICS

FINAL DISPOSITION NOTICE SENT TO IB

13/10/2021

FIMP

FINAL DISPOSITION PROCESSED

13/10/2021

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

22/09/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

22/06/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/04/2021

PUBO

PUBLISHED FOR OPPOSITION

06/04/2021

GPNX

NOTIFICATION PROCESSED BY IB

05/04/2021

CORN

CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED

18/03/2021

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

17/03/2021

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

17/03/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

17/03/2021

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

28/02/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

27/02/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

26/02/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

26/02/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

26/02/2021

RFNT

REFUSAL PROCESSED BY IB

09/11/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

16/10/2020

RFRR

REFUSAL PROCESSED BY MPU

16/10/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

24/09/2020

CNRT

NON-FINAL ACTION WRITTEN

23/09/2020

DOCK

ASSIGNED TO EXAMINER

18/09/2020

MAFR

APPLICATION FILING RECEIPT MAILED

15/09/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/09/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

10/09/2020

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace OPTI-OX ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.